Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care.
Mario Luca MorieriRiccardo CandidoSimona FrontoniOlga DisoteoAnna SoliniGian Poalo Fadininull nullPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
The study supports the potential of early implementation of oral semaglutide as a strategy to overcome therapeutic inertia and enhance T2D management.